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Materials and methods
All reagents were commercially available and used as supplied without further purification. Peptide Br-C10H21CO-GGGGGGGCCERGDS (PA) was prepared by solid phase peptide synthesis, purified by HPLC and confirmed by LCMS by Sangon Biotech Co., Ltd (Shanghai, China).
1 H NMR and 13 C HMR spectra were recorded with a Bruker Avance DMX 400 spectrometer using the deuterated solvent as the lock and the residual solvent or TMS as the internal reference. Transmission electron microscopic (TEM) investigations were carried out on a HITACHI HT-7700 instrument. Scanning electron microscopy (SEM) investigations were carried out on a JEOL 6390LV instrument. UV-vis spectra were taken on a PerkinElmer Lambda 35 UV-vis spectrophotometer. The fluorescence experiments were conducted on a RF-5301 spectrofluorophotometer (Shimadzu Corporation, Japan). The ITC experiment was performed on a VP-ITC micro-calorimeter (Microcal, USA). Photographs were taken with a Cannon 550D. Dynamic light scattering was carried out on a Malvern Nanosizer S instrument at room temperature. Fluorescence images were taken with Olympus IX71 inverted fluorescence microscope. 2D and 3D CLSM images were taken on a Zeiss CLSM system. Flow cytometry was carried out on Cytoflex S (Berkman, Germany). After washing with PBS, the cells were stained with Lyso-tracker green, fixed with 4%
formaldehyde and then stained with DAPI. For 3D CLSM, the A549 tumor spheroid was cultured on sphera 96-well U-bottom 3D cell culture plate for 4 days and then stained by TPP@NPs for 12 h, Lyso-tracker Green for 2 h and Hoechst 33342 for 1 h.
Target ability analysis of TPP@NPs. We used endothelial cells ( were injected with 50 μL of PBS. Group (iii) to (vi) were injected with 50 μL of TPP@NPs with concentrations of 0.1, 0.5 and 1.0 mg mL -1 , respectively. The injection was intratumoral injection. After 30 min, the mice were irradiated under 660 nm laser light at 300 mW cm -2 for 3 min, and another 3 min of irradiation after an interval of 1 min (for avoiding temperature rising under laser). The mice were normally fed after PDT and the body weight and tumor volume were recorded at determined time. After 10 days, the mice were sacrificed and tumors were collected to image and measure the size and weight.
We would like to use in vivo PDT to estimate the anti-tumor efficiency of the supramolecular peptide and to illustrate this therapeutic system definitely having more S5 potentials in cancer treatment. Considering intratumoral injection is more effective, we chose intratumoral injection to dose TPP@NPs.
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Synthesis of PyP, P5 and G1
Preparation of 4-methylpyridinium-C10H21CO-GGGGGGGCCERGDS bromide (PyP): 
Preparation of per-tri(ethyleneoxide)pillar[5]arene (P5): P5 was synthesized according
to a published procedure. [S1] Briefly, per-hydroxylpillar [5] arene was stirred with excess 2-(2'-(2''-methoxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate [S2] in presence of 
